[{"id":"98586a6d-8fa3-4c84-a3a4-dac719a7444a","acronym":"","url":"https://clinicaltrials.gov/study/NCT01967758","created_at":"2021-01-18T08:56:41.914Z","updated_at":"2024-07-02T16:37:07.758Z","phase":"Phase 1","brief_title":"Phase I Study of Safety and Immunogenicity of ADU-623","source_id_and_acronym":"NCT01967758","lead_sponsor":"Providence Health \u0026 Services","biomarkers":" CTAG1B","pipe":"","alterations":" ","tags":["CTAG1B"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e ADU-623"],"overall_status":"Completed","enrollment":" Enrollment 11","initiation":"Initiation: 01/08/2014","start_date":" 01/08/2014","primary_txt":" Primary completion: 06/18/2018","primary_completion_date":" 06/18/2018","study_txt":" Completion: 08/15/2018","study_completion_date":" 08/15/2018","last_update_posted":"2018-08-17"}]